Abstract:Acute lung injury (ALI) is associated with overproduction of inflammatory mediators in lung tissue. Previous studies have revealed that inflammation induces activation of phosphodiesterase 4B (PDE4B) accompanied by the production of inflammatory mediators, but the detailed mechanism remains unclear. Here, we focused on the NOD-, LRR- and pyrin domain-containing protein 3(NLRP3) inflammasome complexes to study the crosstalk between PDE4B and NF-E2-related factor 2 (Nrf2). We used global knockout PDE4B or Nrf2 mice to prepare LPS induced acute lung injury model by intratracheally administration, and LPS primed bone marrow-derived macrophages (BMDMs), following overexpression of PDE4B or Nrf2, luciferase activity analysis, and chIP-qPCR analyses. We found that deficiency of PDE4B could potently attenuate the lung histopathological changes, suppress the secretion of pro-inflammatory mediators such as tumor necrosis factor α (TNF-α), interleukin (IL)-1β, IL-6, IL-18, and cleaved caspase-1, 8, and GSDMD accompanied with defective activation of the ROS/Nrf2/NLRP3. Meanwhile deficiency of Nrf2 showed the similar results. Furtherly, overexpression by PDE4B or Nrf2 plasmid transfection in MH-S cells could enhance the Nrf2 or PDE4B expression. Luciferase analysis suggested that Nrf2 activated PDE4B promoter activity, while PDE4B could increase Nrf2 substrate ARE activity in MH-S cells in dose dependent manners. ChIP-qPCR analyses showed that Nrf2 bound to the PDE4B promoter region at ̴ 1532 to ̴1199 position in macrophages. Altogether, deficiency of PDE4B inhibit the inflammasome activation and pyroptosis in LPS stimulated lung injury model and macrophages by regulating ROS/Nrf2/NLRP3 activation. The study provides new insight that PDE4B is required for NLRP3 inflammasome activation by positive feedback with Nrf2.

Ubiquitination of NLRP3 by gp78/Insig-1 restrains NLRP3 inflammasome activation

Phosphodiesterase 4B is Required for NLRP3 Inflammasome Activation by Positive Feedback with Nrf2 in the Early Phase of LPS- Induced Acute Lung Injury

Sequential ubiquitination of NLRP3 by RNF125 and Cbl-b limits inflammasome activation and endotoxemia

Modulatory mechanisms of NLRP3: Potential roles in inflammasome activation

Ezh2 competes with p53 to license lncRNA Neat1 transcription for inflammasome activation

Posttranslational ISGylation of NLRP3 by HERCs enzymes facilitates inflammasome activation in models of inflammation

AKT Controls NLRP3 Inflammasome Activation by Inducing DDX3X Phosphorylation

AA467197 Controls the Hyperactivation of the NLRP3 Inflammasome During Infection

NLRP3 inflammasome activation and cell death

Protein kinase D at the Golgi controls NLRP3 inflammasome activation

PtdIns4P on dispersed trans-Golgi network mediates NLRP3 inflammasome activation

The regulation of NLRP3 inflammasome activation by CCDC50-mediated autophagy

GSK3β mediates the spatiotemporal dynamics of NLRP3 inflammasome activation

Tyrosine Phosphatase SHP2 Negatively Regulates NLRP3 Inflammasome Activation Via ANT1-dependent Mitochondrial Homeostasis

The NLRP3 inflammasome: activation and regulation

E3 Ubiquitin Ligase Nedd4 is a Key Negative Regulator for Non-Canonical Inflammasome Activation

Disruptions in endocytic traffic contribute to the activation of the NLRP3 inflammasome

The NLRP3 inflammasome: molecular activation and regulation to therapeutics

Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors

Palmitoylation prevents sustained inflammation by limiting NLRP3 inflammasome activation through chaperone-mediated autophagy

Distinct changes in endosomal composition promote NLRP3 inflammasome activation